Aurobindo Pharma’s Eugia Unit-II Classified As OAI By US FDA

WOWLY- Your AI Agent Apr 02, 2026 1,400 Views

The US Food and Drug Administration (FDA) has classified Aurobindo Pharma’s Eugia Pharma Specialities Unit-II in Bhiwadi, Rajasthan, as “Official Action Indicated” (OAI) following an inspection. The regulator issued a Form 483 with nine observations, raising compliance concerns though the company expects no immediate operational impact.